Universität zu Köln

Journal Article

Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley, V, Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit and Schulte, Johannes H. (2021). Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Lancet Oncol., 22 (12). S. 1764 - 1777. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur. J. Cancer, 136. S. 52 - 69. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Moreno, Lucas ORCID: 0000-0002-0708-1670, Caron, Hubert, Geoerger, Birgit, Eggert, Angelika, Schleiermacher, Gudrun, Brock, Penelope, Valteau-Couanet, Dominique, Chesler, Louis ORCID: 0000-0001-7842-2068, Schulte, Johannes H., De Preter, Katleen, Molenaar, Jan, Schramm, Alexander ORCID: 0000-0001-7670-7529, Eilers, Martin, Van Maerken, Tom, Johnsen, John Inge, Garrett, Michelle, George, Sally L., Tweddle, Deborah A., Kogner, Per ORCID: 0000-0002-2202-9694, Berthold, Frank, Koster, Jan ORCID: 0000-0002-0890-7585, Barone, Giuseppe, Tucker, Elizabeth R., Marshall, Lynley, Herold, Ralf ORCID: 0000-0002-8148-6748, Sterba, Jaroslav, Norga, Koen, Vassal, Gilles and Pearson, Andrew D. J. (2017). Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. Expert. Opin. Drug Discov., 12 (8). S. 801 - 812. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1746-045X

Moreno, Lucas, Guo, Dongjing, Irwin, Meredith S., Berthold, Frank ORCID: 0000-0002-7613-1723, Hogarty, Michael ORCID: 0000-0002-9221-4852, Kamijo, Takehiko, Morgenstern, Daniel ORCID: 0000-0002-4859-1108, Pasqualini, Claudia, Ash, Shifra, Potschger, Ulrike, Ladenstein, Ruth, Valteau-Couanet, Dominique, Cohn, Susan L., Pearson, Andrew D. J. and London, Wendy B. . A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. Pediatr. Blood Cancer. HOBOKEN: WILEY. ISSN 1545-5017

Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K. and Valteau-Couanet, Dominique (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, 128 (21). S. 3775 - 3784. HOBOKEN: WILEY. ISSN 1097-0142

Schulte, Johannes H., Moreno, Lucas, Ziegler, David Simon, Marshall, Lynley V., Zwaan, C. Michel, Irwin, Meredith, Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Fischer, Matthias and Geoerger, Birgit (2020). Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755